Remove Cannabinoids Remove Oil Remove Patients Remove Pharmaceutical
article thumbnail

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.

article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MOTAGON to Become the First Pharmaceutical Company in the Czech Republic to Supply Medical Cannabis Extracts to Patients

Cannabis Law Report

. – August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

article thumbnail

ZYUS Life Sciences Launches Two Softgel Cannabinoid Products for Direct to Patient Sales in Canada

Cannabis Law Report

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

article thumbnail

How to make CBD oil with CBD crystals

Alchimia

The use of cannabinoids for the treatment of various ailments or symptoms has exploded in recent years, with dozens of CBD-rich products now freely available in many countries. In many cases, CBD oil can be prepared with a few cannabinoid-rich cannabis flowers, some vegetable oil and a little patience.

Oil 52
article thumbnail

ZYUS Life Sciences Launches New Medical Cannabinoid Formulation for Direct to Patient Sales in Canada

Cannabis Law Report

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential. About ZYUS Life Sciences Inc. Visit www.zyus.com.

article thumbnail

Why People Choose THC Oil: Its Benefits and Effects

Cannabis Law Report

That’s why some people choose THC oil. THC Oil Benefits. When a person uses a THC oil pen ( vapingdaily gives more details) to ingest this cannabinoid, it can benefit them in different ways. These include the potential to relieve symptoms like nausea and vomiting in cancer patients after undergoing chemotherapy treatment.

Oil 104